We tested the drug sensitivity of OKMS#1, MCF7, SKBR3, MDAMB231 to two drugs canonically used for breast cancer treatment, i.e., 4-Hydrotamoxifen (a hormonal therapy) and Trastuzumab (targeted therapy against HER2 positive cells). Here, ERBB2 is linked to breast cancer.